Do you agree that FDA may want to see the full safety database from the GALA study? Speaking objectively (rather than as a MNTA investor), that's what I would probably ask for if I were an FDA reviewer.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”